Christopher Ghadban is an accomplished investor and entrepreneur with extensive experience in the life sciences and biotechnology sectors. Currently serving as an Investor at The Venture Collective since 2024, Christopher is also the Founder of 1bio, established in 2021. In addition, Christopher holds various board observer roles at several innovative companies such as Ruby Bio, Unnatural Products Inc., InGel Therapeutics, Coding Bio, and Laguna Bio, all focused on advancing sustainable and therapeutic biomanufacturing solutions. Previously, Christopher contributed as an Advisor to Nucleate and worked as a Principal at Alix Ventures, supporting early-stage life science startups. Academic qualifications include an MBA in Health Care Management from The Wharton School and dual master's degrees in Bioengineering and Chemical Engineering from Tufts University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices